A new minimally ablative stem cell transplantation procedure in high-risk patients not eligible for nonmyeloablative allogeneic bone marrow transplantation. [electronic resource]
Producer: 20040520Description: 557-61 p. digitalISSN:- 0268-3369
- Adult
- Busulfan -- administration & dosage
- Cyclosporine -- therapeutic use
- Female
- Graft Survival
- Graft vs Host Disease -- drug therapy
- Hematopoietic Stem Cell Mobilization
- Hematopoietic Stem Cell Transplantation -- methods
- Humans
- Immunosuppressive Agents -- therapeutic use
- Male
- Middle Aged
- Neoplasms -- mortality
- Patient Selection
- Pilot Projects
- Transplantation Conditioning -- methods
- Transplantation, Homologous
- Treatment Outcome
- Vidarabine -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.